Medical Device Company Updates MMSEA Section 111 Reporting Policy

North America - United States

A medical device company reviewed and updated its reporting policy for Section 111 of the Medicare, Medicaid and SCHIP Extension Act of 2007 (MMSEA). FaegreBD counseled the company during the review. FaegreBD confirmed the applicability of the Section 111 reporting requirements and reviewed the company's policies and procedures related to Section 111 reporting. As a result of the audit, certain changes were implemented to shore up the company's Section 111 compliance program.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。